Drug details:
Molecular formula: C₂₃H₄₀N₈O₈

Standard name: (2S)-2-[[(2S)-2-[[(2S,3S,6S)-3-[(3R,4S)-5-[(4R)-2-amino-1-carbamoyl-4,5-dihydroimidazol-4-yl]-3,4-dihydroxypentyl]-6-methyl-5-oxopiperazine-2-carbonyl]amino]propanoyl]amino]-3-methylbutanoic acid

Curated SMILES: C[C@H]1C(=O)N[C@H]([C@H](N1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O)CC[C@H]([C@H](C[C@@H]2CN(C(=N2)N)C(=O)N)O)O

Evidence for compound's anti-virulence activity:

Escherichia
Related VF: TTSS (Type III secretion system)
Target: Not determined
Drug effect: Markedly inhibit EPEC-induced hemolysis.
Max phase: Preclinical (in vitro)
Publication:
Iwatsuki M, et al., 2008. Guadinomines, Type III secretion system inhibitors, produced by Streptomyces sp. K01-0509. I: taxonomy, fermentation, isolation and biological properties. J Antibiot (Tokyo) 61(4):222-9.